Bard C R Inc (BCR) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Bard C R Inc  (BCR)
 

Bard C R Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BCR Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 5.09 % 3.27 % 5.43 % 5.47 %
Q / Q Revenue Growth (Q3 MRQ) 1.03 % 0.45 % 1.61 % -1.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 7.12 % 0.05 % 6.63 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 1.25 % 1.01 % 1.22 % 1.35 %
Revenue 5 Year Average Growth 5.1 % 6.09 % 4.44 % 2.23 %


BCR's Growth Comparisons in III. Quarter 2017




Softening Bard C R Inc's 5.09% year on year Revenue improvement, in the third quarter 2017 to 990 millions, outgrows the 3.27% growth in the Medical Equipment & Supplies industry, but Bard C R Inc's growth compares unfavorably, to the 5.43% Revenue growth in the Healthcare sector.

Comparing the company's Revenue to the second quarter results, sales were higher by 1.03% . On the yearly basis, average annual sales growth for Bard C R Inc is 5.1%, while S & P 500's including only Businesses with the third quarter 2017 earnings, average annual sales growth is 2.23% over the past five years.

BCR Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
United States
-
-
Europe
-
-
Japan
-
-
Rest of the World
-
-
Total
-
-
Rest of World
-
-
Vascular
-
-
Urology
-
-
Oncology
-
-
Surgery
-
-


Growth Rates of BCR's Income in the third quarter 2017


BCR Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 6.09 % 22.49 % -1.78 % 3.92 %
Sequential Operating Income Change (Q3 MRQ) 0.43 % 14.28 % 13.78 % 6.85 %
Y / Y Operating Income Growth (Q3 TTM) 54.26 % 23.52 % 7.61 % 27.09 %
Sequential Operating Income Growth (Q3 TTM) 1.48 % 5.04 % -3.59 % 1.59 %
Operating Income 5 Year Avg. Change 2.96 % 1.43 % -2.98 % 2.72 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -2.39 % 44.44 % 26.81 % 14.15 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) -32.64 % 27.29 % 70.6 % 6.55 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 12.66 % 9.29 % -19.27 % 16.93 %
Sequential Income from Cont. Ops. Change (Q3 TTM) -0.4 % 9.61 % -0.93 % 4 %
Income from Cont. Ops. 5 Year Avg. Change 10.13 % 9.31 % -0.17 % 1.59 %

BCR Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -2.39 % 42.92 % 26.23 % 10.83 %
Q / Q Net Income Growth (Q3 MRQ) -32.64 % 25.87 % 85.33 % 3.72 %
Y / Y Net Income Change (Q3 TTM) 12.66 % 6.31 % -31.59 % 11.29 %
Sequential Net Income Change (Q3 TTM) -0.4 % 9.31 % -20.4 % 1.36 %
Net Income 5 Year Avg. Growth 10.13 % 9.05 % 2.88 % 1.75 %

BCR's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -1.54 % 36.48 % 26.81 % 14.15 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) -32.63 % 27.66 % 70.6 % 6.55 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 13.45 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) -0.26 % - - 4.04 %
EPS from Cont. Ops. 5 Year Avg. Growth 13.78 % 4.8 % -0.17 % 1.59 %



BCR EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -1.57 % 35.04 % 26.23 % 1.59 %
Q / Q EPS Net Growth (Q3 MRQ) -32.8 % 26.23 % 85.33 % 3.72 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 22.83 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) -0.26 % - - 0.87 %
EPS Net 5 Year Avg. Change 13.76 % 9.05 % 2.88 % 1.75 %



Although the Medical Equipment & Supplies industry saw advancing EPS by 35.04%, Bard C R Inc announced -1.57% year on year income per share decline in the third quarter, to $ 1.25, and underperformed the 26.23% EPS increase in the Healthcare sector. Although both Medical Equipment & Supplies industry and Healthcare sector posted higher gains than 10.83% overall market increase, Bard C R Inc was trailing overall market in the third quarter.

Bottom-line fell by -32.8% from the second quarter results. Comparing the annual growth, income per share of 13.76% on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2017 earnings, average yearly income per share growth is 1.75%. Bard C R Inc grew faster than the market.

BCR Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 27.99 % 25.8 % 28.98 % 47.46 %
Sequential Free Cash Flow Change (Q3 MRQ) 36.86 % 15.22 % 14.11 % 33.13 %
Y / Y Free Cash Flow Change (Q3 TTM) 70.16 % 8.68 % 9.83 % 2.13 %
Sequential Free Cash Flow Change (Q3 TTM) 7.15 % 0.85 % -0.55 % 3.48 %
Free Cash Flow 5 Year Avg. Change -7.28 % 4.17 % 1.4 % 0.33 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 13.16 % - -10.46 %
Sequential Net Cash Flow Change (Q3 MRQ) - -96.2 % 253.79 % 127.56 %
Y / Y Net Cash Flow Change (Q3 TTM) - - - -76.99 %
Sequential Net Cash Flow Change (Q3 TTM) - 0.51 % 96.91 % -27.53 %
Net Cash Flow 5 Year Avg. Change - - -28.36 % -11.79 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -41.57 % -5.85 % 4.06 % 6.86 %
Sequential Capital Expenditures Change (Q3 MRQ) -38.24 % 3.8 % 6.01 % -5.36 %
Y / Y Capital Expenditures Change (Q3 TTM) 18.58 % 3.81 % 10.02 % 4 %
Sequential Capital Expenditures Change (Q3 TTM) -12.71 % -0.02 % 0.55 % -0.71 %
Capital Expenditures 5 Year Avg. Change 7.23 % 5.34 % 7.91 % 0.98 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.